Novel CpG depleted and codon optimised CFTR cDNAs maintain the structure and fuction of CFTR protein. (2006)

Varathalingam, A., Lawton, A. E., Munkonge, F. M., Chan, M., Somerton, L., Griesenbach, U., Alton, E. W. F. W., Pringle, I. A., Hyde, S. C. & Gill, D. R.

Download   Back

CpG dinucleotides present in plasmid DNA (pDNA) are known to contribute to the induction of an acute inflammatory response when delivered to the lungs of experimental animal models and patients with Cystic Fibrosis. Reduction in the number of CpGs within plasmid expression vectors has been shown to reduce the host inflammatory response to non-viral gene transfer. The standard Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) cDNA contains 59 CpG motifs, therefore we have generated a CFTR cDNA (termed soCFTR) which has all CpGs removed without altering the amino acid sequence. In addition this cDNA is codon optimised resulting in a sequence that is only 77% identical to the standard CFTR cDNA. To study the impact of soCFTR cDNA on CFTR protein we investigated the structure and function of the CFTR protein in cell culture. Western blotting showed that soCFTR cDNA directed the expression of abundant CFTR protein that was correctly glycosylated. SoCFTR cDNA directed CFTR function that was also confirmed by Iodide125 effllux analysis. TaqMan RT-PCR assay confirmed the presence of vector specific CFTR mRNA in vivo at day 14 following nasal perfusion (FABP CF mice, n=21, Mann Whitney p<0.05). These data confirm that CpG depletion and codon optimisation of CFTR cDNA does not alter the CFTR structure and function in cell culture and can lead to persistent CFTR expression in vivo. Non-viral mediated CFTR gene transfer with this new form of the CFTR cDNA will be investigated in a variety of model systems in preparation for clinical studies.

Introductory Videos
Medical Futures Innovation Award 2011
Twitter Feed
About Us
Contact Us
Lab Events
Environemental Policy
About this Site

Google Site Search

Site Feedback Form

All Site Images



How the Consortium works/FAQs

Consortium Website

Centre for Molecular Medicine, Edinburgh
The Roslin Institute
Dep of Gene Therapy, Imperial



The Run-in Study

Single Dose Clinical Trial

Multi Dose Clinical Trial


Our Research

Non-viral Vector Development

Aerosol Mediated Gene Delivery

Viral Vector Development

Taqman Core Facility

Cystic Fibrosis

History of CF

Discovery of the CFTR Gene

CFTR Protein Structure

CFTR Function

CF Links


Gene Therapy

Introduction to Gene Therapy

Other CF Gene Therapy Groups

Why use Gene Therapy for CF

Target Cells for CF Gene Therapy

Barriers for CF Gene Therapy

Clinical Trials

Gene Therapy Successes

Gene Therapy Links




Papers in Journals

Conference Posters & Presentations

Book Chapters

D.Phil Theses



Gene Therapy Seminars


Directions & Venue